Chemical Communication front page
blood cells

Trau Lab Research Overview

Our research focus on developing diagnostic devices for early detection of diseases such as cancer, when it is most responsive to treatment which also provides the greatest social and economic benefits to society. Nanotechnology offers the promise of miniaturised, inexpensive, flexible and robust “plug-and-play” molecular reading systems which can be effectively deployed to detect diseases in a clinical setting.

 

NEWS

9-14 November 2015

HOBART: NBCF National Workshop on Epigenetic Biosensors & Epigenetics Conference

Trau group attend NBCF Workshop and Epigenetics Conference